885 related articles for article (PubMed ID: 15664112)
21. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia.
Geschwind D; Karrim J; Nelson SF; Miller B
Ann Neurol; 1998 Jul; 44(1):134-8. PubMed ID: 9667603
[TBL] [Abstract][Full Text] [Related]
22. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease.
Okuizumi K; Onodera O; Namba Y; Ikeda K; Yamamoto T; Seki K; Ueki A; Nanko S; Tanaka H; Takahashi H; Oyanagi K; Mizusawa H; Kanazawa I; Tsuji S
Nat Genet; 1995 Oct; 11(2):207-9. PubMed ID: 7550352
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E genotypes in sporadic early and late-onset Alzheimer's disease.
Kowalska A; Florczak J; Pruchnik-Wolińska D; Kraszewski A; Wender M
Arch Immunol Ther Exp (Warsz); 1998; 46(3):177-81. PubMed ID: 9704150
[TBL] [Abstract][Full Text] [Related]
24. Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease.
Zubenko GS; Stiffler S; Stabler S; Kopp U; Hughes HB; Cohen BM; Moossy J
Am J Med Genet; 1994 Sep; 54(3):199-205. PubMed ID: 7810577
[TBL] [Abstract][Full Text] [Related]
25. Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases.
Itabashi S; Arai H; Matsui T; Matsushita S; Muramatsu T; Higuchi S; Trojanowski JQ; Sasaki H
Exp Neurol; 1998 Jun; 151(2):237-40. PubMed ID: 9628759
[TBL] [Abstract][Full Text] [Related]
26. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
[TBL] [Abstract][Full Text] [Related]
27. High apolipoprotein E epsilon 4 allele frequency in age-related memory decline.
Blesa R; Adroer R; Santacruz P; Ascaso C; Tolosa E; Oliva R
Ann Neurol; 1996 Apr; 39(4):548-51. PubMed ID: 8619535
[TBL] [Abstract][Full Text] [Related]
28. [Frequency of the APOE-4 allele in Alzheimer's disease and its variation with age in Asturias (Spain)].
Alvarez V; Alvarez R; Peña J; Lahoz CH; Martínez C; Menéndez-Guisasola L; Salas-Puig J; Morís G; Uría D; Menes BB; Ribacoba R; Vidal JA; Coto E
Med Clin (Barc); 1999 Oct; 113(12):441-3. PubMed ID: 10570509
[TBL] [Abstract][Full Text] [Related]
29. Initial results of a genome survey for novel Alzheimer's disease risk genes: association with a locus on the X chromosome.
Zubenko GS; Stiffler JS; Hughes HB; Hurtt MR; Kaplan BB
Am J Med Genet; 1998 Mar; 81(2):196-205. PubMed ID: 9613863
[TBL] [Abstract][Full Text] [Related]
30. ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome.
Martins RN; Clarnette R; Fisher C; Broe GA; Brooks WS; Montgomery P; Gandy SE
Neuroreport; 1995 Jul; 6(11):1513-6. PubMed ID: 7579137
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies.
Nalbantoglu J; Gilfix BM; Bertrand P; Robitaille Y; Gauthier S; Rosenblatt DS; Poirier J
Ann Neurol; 1994 Dec; 36(6):889-95. PubMed ID: 7998776
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease.
Levy-Lahad E; Lahad A; Wijsman EM; Bird TD; Schellenberg GD
Ann Neurol; 1995 Oct; 38(4):678-80. PubMed ID: 7574468
[TBL] [Abstract][Full Text] [Related]
33. Association of apolipoprotein E allele epsilon 4 with late-onset sporadic Alzheimer's disease.
Lucotte G; Visvikis S; Leininger-Müler B; David F; Berriche S; Réveilleau S; Couderc R; Babron MC; Aguillon D; Siest G
Am J Med Genet; 1994 Sep; 54(3):286-8. PubMed ID: 7810590
[TBL] [Abstract][Full Text] [Related]
34. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival.
van Duijn CM; de Knijff P; Wehnert A; De Voecht J; Bronzova JB; Havekes LM; Hofman A; Van Broeckhoven C
Ann Neurol; 1995 May; 37(5):605-10. PubMed ID: 7755355
[TBL] [Abstract][Full Text] [Related]
35. A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution.
Zubenko GS; Hughes HB; Stiffler JS; Hurtt MR; Kaplan BB
Genomics; 1998 Jun; 50(2):121-8. PubMed ID: 9653640
[TBL] [Abstract][Full Text] [Related]
36. A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease.
Steffens DC; Plassman BL; Helms MJ; Welsh-Bohmer KA; Saunders AM; Breitner JC
Biol Psychiatry; 1997 Apr; 41(8):851-6. PubMed ID: 9099411
[TBL] [Abstract][Full Text] [Related]
37. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
Agarwal R; Tripathi CB
Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
[TBL] [Abstract][Full Text] [Related]
38. Experience of ApoE study in Thai elderly.
Senanarong V; Harnphadungkit K; Lertrit P; Mitrpant C; Udompunthurak S; Limwong C; Prayoonwiwat N; Poungvarin N
J Med Assoc Thai; 2001 Feb; 84(2):182-7. PubMed ID: 11336076
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis.
Mui S; Rebeck GW; McKenna-Yasek D; Hyman BT; Brown RH
Ann Neurol; 1995 Sep; 38(3):460-3. PubMed ID: 7668834
[TBL] [Abstract][Full Text] [Related]
40. Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it.
Martorell L; Virgos C; Valero J; Coll G; Figuera L; Joven J; Pocoví M; Labad A; Vilella E
Mol Psychiatry; 2001 May; 6(3):307-10. PubMed ID: 11326299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
